<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131160">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01955577</url>
  </required_header>
  <id_info>
    <org_study_id>N-20130033</org_study_id>
    <nct_id>NCT01955577</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplement for Patients With Tibial Fracture</brief_title>
  <official_title>Vitamin D Supplement for Patients With Tibial Fracture Treated With an External Ring Fixator. A Prospective Randomized Double-blind Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern Orthopaedic Division, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northern Orthopaedic Division, Denmark</source>
  <oversight_info>
    <authority>Denmark: The Danish National Committee on Biomedical Research Ethics</authority>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to study:

        1. the frequency of vitamin D deficiency at patients with tibial fracture treated with an
           external ring fixator

        2. if vitamin D supplement facilitates fracture healing

        3. a possible relation between vitamin D deficiency and the risk of complications and the
           time of fracture healing
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      External ring fixator is a widespread and well-known method to treate complex tibial
      fractures. The effect of treating proximal and distal intra-articulatio tibial fractures has
      been positive until now.

      Complications such as malunions, nonunions, re-fractures and extended time of ring fixation
      will occur in 5-10% of all tibial fractures in patients treated with ring fixator. Factors
      like trauma of soft tissue, smoking and compromised afflux of blood are associated with a
      higher frequency of nonunion.

      It has been documented that elderly people with hypovitaminosis D have a higher risk of
      being affected by osteoporosis and fractures. Furthermore, there is a possible association
      between the severity of fracture and hypovitaminosis. The time of fracture healing is also
      extended compared to fractures in patients who are not affected by osteoporosis.

      Until now research has not shown whether the fracture healing process is influenzed by
      vitamin D.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Time of fracture healing</measure>
    <time_frame>20 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Time of fracture healing, i.e. time from osteosynthesis until fracture healing is clinically and radiologically registered.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitamin D receptor DNA</measure>
    <time_frame>20 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>A DNA blood sample will be taken in order to analyse how the skeleton reacts on vitamin D supplement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>20 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Registration of possible complications, i.e. nonunion, malunion, number of check-ups, infections, re-surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Tibial Fracture</condition>
  <arm_group>
    <arm_group_label>Vitamin D3 cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000IU x3 daily in a period of 14 days. After 14 days 1000IU x 1 daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo orally everyday</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One placebo pill x3 daily in a period of 14 days. After 14 days x1 placebo pill daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo orally everyday</intervention_name>
    <arm_group_label>Placebo orally everyday</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3 cholecalciferol</intervention_name>
    <arm_group_label>Vitamin D3 cholecalciferol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with tibial fracture

          -  A written signed statement of consent

          -  All potential patients primary with osteosynthesis Iliazov

        Exclusion Criteria:

          -  Tumours in bone

          -  Metastases to bone marrow

          -  Chronic renal disease

          -  Drug abuse

          -  Abuse of alcohol (&gt;21 drinks a week for men and &gt; 14 drinks a week for women)

          -  Morbus Cushing disease

          -  Glandulae thyroid disease

          -  Pregnancy

          -  Chronic steroid therapy

          -  Hepatic insufficiency

          -  Sarcoidosis, tuberculosis or silocosis

          -  Patients under 18 years

          -  Inability to take medicine

          -  Adverse effects of vitamin D or allergic to vitamin D
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tine L. Bennedsen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tine L. Bennedsen, M.D.</last_name>
    <phone>99 32 63 46</phone>
    <phone_ext>45</phone_ext>
    <email>tilb@rn.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juozas Petruskevicius, M.D., Ph.D.</last_name>
    <phone>99 32 52 40</phone>
    <phone_ext>45</phone_ext>
    <email>juope@rn.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <state>Region Northern Jutland</state>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tine L. Bennedsen, M.D.</last_name>
      <phone>99 32 63 46</phone>
      <phone_ext>45</phone_ext>
      <email>tilb@rn.dk</email>
    </contact>
    <contact_backup>
      <last_name>Juozas Petruskevicius, M.D., Ph.d.</last_name>
      <phone>99 32 52 40</phone>
      <phone_ext>45</phone_ext>
      <email>juope@rn.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Tine L. Bennedsen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juozas Petruskevicius, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Steinbauer, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Torleif Trydal, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sten Rasmussen, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 28, 2014</lastchanged_date>
  <firstreceived_date>September 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D deficiency</keyword>
  <keyword>Ring fixator</keyword>
  <keyword>Tibial fracture</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
